Sanofi SA (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 234   

Articles published

SNY 46.50 -0.23 (-0.49%)
price chart
Sanofi Fires CEO Following Clash With Board
Sanofi SA (ADR) (SNY) announced today that the company's board has decided to oust Chief Executive Officer Christopher Viehbacher, finally putting the rumors to rest.
Sanofi Ousts CEO Christopher Viehbacher, Stock Down - Update  Nasdaq
Related articles »  
Sanofi SA (SNY), Regeneron Pharmaceuticals (REGN) Eczema Drug Gets FDA ...
Sanofi SA (ADR) (NYSE:SNY) and its US-based partner Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) jointly developed experimental drug dupilumab has been granted breakthrough therapy designation by the US Food and Drug Administration for use ...
Related articles »  
Sanofi SA (ADR) Receives Analyst Recommendation
Sanofi downgraded to Underweight from Neutral at JPMorgan. JPMorgan downgraded Sanofi to Underweight saying the Toujeo launch will likely be underwhelming while consensus earnings expectations are likely too high.
Former Employee Files Lawsuit Against Sanofi SA (ADR) (NYSE:SNY)  USMarketsDaily (blog)
Average Broker Consensus on Sanofi SA (ADR)  Wall Street Pulse
Sanofi SA (SNY) Pipeline Deserves More Credit, Says Citi
Citigroup Inc (NYSE:C), which remains neutral on Sanofi SA (ADR) (NYSE:SNY) stock, thinks that the company's pipeline deserves more credit despite the challenges its diabetes portfolio is currently facing.
AbbVie Inc (ABBV), Celgene Corporation (CELG), Sanofi SA (ADR) (SNY ...  StockWise Daily
Related articles »  
Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Sanofi SA (ADR) (NYSE:SNY) announced before US markets opened for trading Tuesday that the US Food and Drug Administration (FDA) has approved its Priftin (rifapentine) tablets for the treatment of latent tuberculosis infection.
Related articles »  
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Shares of Sanofi SA (ADR) (SNY) continue their downward journey since Chris Viehbacher was ousted from his position as CEO late October by the company's board of directors in the coup led by Chairman Serge Weinberg.
Related articles »  
Buzz Stocks: Orbital Sciences Corp, Sanofi SA (ADR), and American Realty ...
Futures are little changed this morning, as investors await this afternoon's policy statement from the Federal Open Market Committee (FOMC).
Deutsche Bank Downgrades Sanofi SA  Benzinga
Sanofi SA Downgraded by Barclays (SNY)  sleekmoney
Related articles »  
Sanofi And Novo Nordisk's Basal-Insulin Battle Continues
Sanofi SA (ADR) (SNY) and Novo Nordisk A/S (ADR) (NVO) are the two main players in the ongoing race for developing effective basal insulin therapies for the treatment of diabetes.
Related articles »  
Sanofi (SNY) Expects $37.6 Billion Revenues From New Drugs
Sanofi SA (ADR) (NYSE:SNY), which has recently been in the limelight for the much publicized ousting of its former CEO Christopher Viehbacher, expressed confidence in its drug pipeline in a statement today.
Related articles »  
Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (ADR) (NYSE:GSK), Sanofi SA ...
Security analysts are predicting that in near future, some giant companies that have highest yields on their dividends may be forced to cut it and names which are rumoring in the markets are Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK ...
Related articles »